Home › Funds › Stonepine Capital Management, LLC › GOSS

Stonepine Capital Management, LLC position in GOSS

GOSSAMER BIO INC · Health Care

Stonepine Capital Management, LLC reported holding 63,039 shares of GOSS (GOSSAMER BIO INC) in its Q3 2026 13F filing — a position valued at US$747K, representing 0.57% of its reported portfolio and ranking #34 among its reported holdings. Stonepine Capital Management, LLC has disclosed GOSS holdings in 4 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)63.04K sh
Reported value held$747.01K
Portfolio Weight0.57%
First reportedQ3 2023
Last changeNew
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Stonepine Capital Management, LLC's GOSS position evolved

Stonepine Capital Management, LLC first disclosed a stake in GOSS in Q3 2023 at 3,339,405 shares (US$2.8M). Across 4 filings, Stonepine Capital Management, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 63,039 shares valued at US$747K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.34M $2.78M New
Q3 2025 204.77K $538.54K New
Q4 2025 204.77K $634.79K Hold
Q3 2026 63.04K $747.01K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GOSS and 13F data

GOSS (GOSSAMER BIO INC) is a Health Care company. 7 other funds we track also report a position in GOSS — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$11.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GOSS

All GOSS fund holders →

FAQ

How long has Stonepine Capital Management, LLC held GOSS?

Stonepine Capital Management, LLC has disclosed GOSS holdings in 4 of the last 13 reported quarters, going back to Q3 2023.

What is Stonepine Capital Management, LLC's current position in GOSS?

As of Q3 2026, Stonepine Capital Management, LLC holds 63.04K shares of GOSS (GOSSAMER BIO INC), valued at $747.01K, representing 0.57% of its reported portfolio and ranking #34.

Has Stonepine Capital Management, LLC been buying or selling GOSS?

In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC newly opened its position in GOSS.

Which other funds hold GOSS?

Other major institutional holders of GOSS include TANG CAPITAL MANAGEMENT LLC, among 7 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.